Andrey L Konevega
Overview
Explore the profile of Andrey L Konevega including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1685
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garaeva L, Komarova E, Emelianova S, Putevich E, Konevega A, Margulis B, et al.
Biomedicines
. 2025 Jan;
12(12.
PMID: 39767665
Stress protein HSP70 administered exogenously has demonstrated high potential as an efficient adjuvant in antitumor immune response. To enhance the antigen-presenting activity, bioavailability, and stability of exogenous recombinant human HSP70,...
2.
Panteleev P, Pichkur E, Kruglikov R, Paleskava A, Shulenina O, Bolosov I, et al.
Nat Commun
. 2024 Oct;
15(1):8925.
PMID: 39414793
The antimicrobial resistance crisis along with challenges of antimicrobial discovery revealed the vital necessity to develop new antibiotics. Many of the animal proline-rich antimicrobial peptides (PrAMPs) inhibit the process of...
3.
Kil Y, Pichkur E, Sergeev V, Zabrodskaya Y, Myasnikov A, Konevega A, et al.
FEBS J
. 2024 Jun;
291(16):3686-3705.
PMID: 38825733
The most extensively studied β-d-galactosidases (EC3.2.1.23) belonging to four glycoside hydrolase (GH) families 1, 2, 35, and 42 are widely distributed among Bacteria, Archaea and Eukaryotes. Here, we report a...
4.
Volynkina I, Bychkova E, Karakchieva A, Tikhomirov A, Zatonsky G, Solovieva S, et al.
Pharmaceuticals (Basel)
. 2024 Feb;
17(2).
PMID: 38399402
The sustained rise of antimicrobial resistance (AMR) causes a strong need to develop new antibacterial agents. One of the methods for addressing the problem of antibiotic resistance is through the...
5.
Volnitskiy A, Shabalin K, Pantina R, Varfolomeeva E, Kovalev R, Burdakov V, et al.
Curr Issues Mol Biol
. 2024 Feb;
46(2):1107-1120.
PMID: 38392188
The OCT4 transcription factor is necessary to maintain cell stemness in the early stages of embryogenesis and is involved in the formation of induced pluripotent stem cells, but its role...
6.
Tereshchenkov A, Khairullina Z, Volynkina I, Lukianov D, Nazarov P, Pavlova J, et al.
Pharmaceutics
. 2024 Jan;
16(1).
PMID: 38276518
Antimicrobial peptides (AMPs) have recently attracted attention as promising antibacterial agents capable of acting against resistant bacterial strains. In this work, an approach was applied, consisting of the conjugation of...
7.
Marina V, Bidzhieva M, Tereshchenkov A, Orekhov D, Sagitova V, Sumbatyan N, et al.
RNA
. 2024 Jan;
30(3):298-307.
PMID: 38164606
Several methods are available to visualize and assess the kinetics and efficiency of elemental steps of protein biosynthesis. However, each of these methods has its own limitations. Here, we present...
8.
Shramova E, Filimonova V, Frolova A, Pichkur E, Fedotov V, Konevega A, et al.
Eur J Pharm Biopharm
. 2023 Nov;
193:208-217.
PMID: 37956784
Photodynamic therapy (PDT) for deep-seated tumors is still challenging due to the limited penetration of visible light through tissues. To resolve this limitation, systems based on bioluminescence resonance energy transfer...
9.
Tran N, Ryzhov V, Volnitskiy A, Amerkanov D, Pack F, Golubev A, et al.
Int J Mol Sci
. 2023 Oct;
24(20).
PMID: 37894830
The potential of standard methods of radiation therapy is limited by the dose that can be safely delivered to the tumor, which could be too low for radical treatment. The...
10.
Tran N, Shtam T, Marchenko Y, Konevega A, Lebedev D
Biomedicines
. 2023 Jun;
11(6).
PMID: 37371822
The development of new methods increasing the biological effectiveness of proton therapy (PT) is of high interest in radiation oncology. The use of binary technologies, in which the damaging effect...